Properties of Dietary Flavone Glycosides, Aglycones, and Metabolites on the Catalysis of Human Endoplasmic Reticulum Uridine Diphosphate Glucuronosyltransferase 2B7 (UGT2B7)

被引:0
作者
Xu, Ting [1 ]
Lv, Yangjun [2 ]
Cui, Yuhan [1 ]
Liu, Dongchen [1 ]
Xu, Tao [1 ]
Lu, Baiyi [1 ]
Yang, Xuan [1 ]
机构
[1] Zhejiang Univ, Key Lab Agroprod Postharvest Handling, Zhejiang Key Lab Agrofood Proc,Natl Local Joint En, Zhejiang Int Sci & Technol Cooperat Base Hlth Food, Hangzhou 310058, Peoples R China
[2] China Coop, Hangzhou Tea Res Inst, Hangzhou 310016, Peoples R China
关键词
flavones; glycosylflavones; glycosides; phenolic acids; nutrition utilization; UDP-GLUCURONOSYLTRANSFERASE; DRUG-METABOLISM; GENE UGT2B7; GLUCURONIDATION; SUBSTRATE; ACID; POLYMORPHISM; ASSOCIATION; INHIBITION; DIVERSITY;
D O I
10.3390/nu15234941
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Flavone glycosides, their aglycones, and metabolites are the major phytochemicals in dietary intake. However, there are still many unknowns about the cellular utilization and active sites of these natural products. Uridine diphosphate glucuronosyltransferases (UGTs) in the endoplasmic reticulum have gene polymorphism distribution in the population and widely mediate the absorption and metabolism of endogenous and exogenous compounds by catalyzing the covalent addition of glucuronic acid and various lipophilic chemicals. Firstly, we found that rutin, a typical flavone O-glycoside, has a stronger UGT2B7 binding effect than its metabolites. After testing a larger number of flavonoids with different aglycones, their aglycones, and metabolites, we demonstrated that typical dietary flavone O-glycosides generally have high binding affinities towards UGT2B7 protein, but the flavone C-glycosides and the phenolic acid metabolites of flavones had no significant effect on this. With the disposition of 4-methylumbelliferone examined by HPLC assay, we determined that 10 mu M rutin and nicotifiorin could significantly inhibit the activity of recombinant UGT2B7 protein, which is stronger than isovitexin, vitexin, 3-hydroxyphenylacetic acid and 3,4-dihydroxyphenylacetic acid. In addition, in vitro experiments showed that in normal and doxorubicin-induced lipid composition, both flavone O-glycosides rutin and flavone C-glycosides isovitexin at 10 mu M had no significant effect on the expression of UGT1A1, UGT2B4, UGT2B7, and UGT2B15 genes for 24 h exposure. The obtained results enrich the regulatory properties of dietary flavone glycosides, aglycones, and metabolites towards the catalysis of UGTs and will contribute to the establishment of a precise nutritional intervention system based on lipid bilayers and theories of nutrients on endoplasmic reticulum and mitochondria communication.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation
    Lewis, Benjamin C.
    Mackenzie, Peter I.
    Elliot, David J.
    Burchell, Brian
    Bhasker, C. Ramana
    Miners, John O.
    BIOCHEMICAL PHARMACOLOGY, 2007, 73 (09) : 1463 - 1473
  • [42] The effect of bovine serum albumin on UDP-glucuronosyltransferase (UGT) 1A9 and 2B7 inhibitory potency
    Lapham, Kimberly
    Novak, Jonathan
    Niosi, Mark
    Leung, Louis Y.
    Goosen, Theunis C.
    DRUG METABOLISM REVIEWS, 2016, 48 : 90 - 90
  • [43] Associations between UGT2B7 polymorphisms and cancer susceptibility: A meta-analysis
    Shen, Ming-Li
    Xiao, An
    Yin, Sun-Jun
    Wang, Ping
    Lin, Xiao-Qian
    Yu, Chen-Bin
    He, Gong-Hao
    GENE, 2019, 706 : 115 - 123
  • [44] Glucuronidation of 1′-hydroxyestragole (1′-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9
    Iyer, LV
    Ho, MN
    Shinn, WM
    Bradford, WW
    Tanga, MJ
    Nath, SS
    Green, CE
    TOXICOLOGICAL SCIENCES, 2003, 73 (01) : 36 - 43
  • [45] Genetic Polymorphism in UDP-Glucuronosyltransferase 2B7 and Colorectal Cancer Risk
    van der Logt, E. M. J.
    te Morsche, R. H. M.
    Groenendaal, N.
    Roelofs, H. M. J.
    de Metz, M.
    van der Stappen, J. W.
    Nagengast, F. M.
    Peters, W. H. M.
    ONCOLOGY RESEARCH, 2008, 17 (07) : 323 - 329
  • [46] Regulation of UDP-Glucuronosyltransferases UGT2B4 and UGT2B7 by MicroRNAs in Liver Cancer Cells
    Wijayakumara, Dhilushi D.
    Mackenzie, Peter I.
    McKinnon, Ross A.
    Hu, Dong Gui
    Meech, Robyn
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 361 (03) : 386 - 397
  • [47] The Letrozole Phase 1 Metabolite Carbinol as a Novel Probe Drug for UGT2B7
    Precht, Jana C.
    Schroth, Werner
    Klein, Kathrin
    Brauch, Hiltrud
    Krynetskiy, Evgeny
    Schwab, Matthias
    Muerdter, Thomas E.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (11) : 1906 - 1913
  • [48] Inhibition of Human UGT2B7 Gene Expression in Transgenic Mice by the Constitutive Androstane Receptor
    Yueh, M. F.
    Mellon, P. L.
    Tukey, R. H.
    MOLECULAR PHARMACOLOGY, 2011, 79 (06) : 1053 - 1060
  • [49] Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5′-diphospho-glucuronosyltransferase (UGT2B17) gene
    Ekstrom, Lena
    Schulze, Jenny J.
    Guillemette, Chantal
    Belanger, Alain
    Rane, Anders
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (06) : 325 - 332
  • [50] Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk
    McGrath, Monica
    Lepine, Johanie
    Lee, I-Min
    Villeneuve, Lyne
    Buring, Julie
    Guillemette, Chantal
    De Vivo, Immaculata
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (03) : 239 - 243